Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical acitretin for facial actinic keratoses
ACTRN12613000333718Phase 2Completed
- Sponsor
- Douglas Pharmaceuticals
- Start
- Apr 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of acitretin in actinic keratosis (AK) (3 arms), sponsored by Douglas Pharmaceuticals. Started Apr 2013; status: completed.
02
Drugs
acitretin
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on ACTRN12613000333718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613000333718.